
Arya News - The Drug Consultative Committee (DCC) agreed to this proposal at its 67th meeting on 17 November, 2025, and the Drug Technical Advisory Board (DTAB) at its 93rd meeting on 16 February, 2026.
NEW DELHI – The Health and Family Welfare Ministry has proposed amendments to the Drugs Rules, 1945, to introduce a separate application form (Form 19-BC) and licence form (Form 20-BC) for the sale of bulk drugs (active or inactive bulk substances), separate from the existing licensing provisions for formulations.
Currently, a common licence covers the wholesale sale of both formulations and bulk drugs. The proposed amendment seeks to establish a dedicated licensing framework for bulk drugs, enabling more focused regulatory oversight of their wholesale sales and greater accountability across the pharmaceutical supply chain.
The Drug Consultative Committee (DCC) agreed to this proposal at its 67th meeting on 17 November, 2025, and the Drug Technical Advisory Board (DTAB) at its 93rd meeting on 16 February, 2026.
Under the proposed framework, the licence will cover the categories of bulk drugs handled by wholesalers, including drugs covered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. Bulk drugs will be sold under the personal supervision of a competent person, strengthening accountability in their distribution and handling.
The changes will provide better control over the wholesale sale of bulk drugs. Enforcement controls regarding antimicrobial resistance and the movement of NDPS drugs will be strengthened. The wholesalers of bulk drugs will need to obtain a separate licence for sale.
To facilitate the transition to the revised licensing requirements, existing licensees will be provided sufficient time to comply with the new provisions. These requirements will come into effect upon the expiration of their current retention period or 12 months after the final publication of the amendments, whichever is later.
Stakeholders and members of the public can submit their objections and suggestions, if any, to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Kartavya Bhawan, or through email at [email protected] , within 30 days from the date on which copies of the Gazette containing the draft rules are made available to the public.